St Charles Pharmaceuticals Inc is categorized under Commercial Medical Research in New Orleans, LA and active since 2000.
St Charles Pharmaceuticals Inc was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Kenneth W Narducy at the company’s single location by writing to 650 Poydras St # 2830, New Orleans, Louisiana LA 70130 or by phoning (504) 524-9600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | St Charles Pharmaceuticals Inc |
| Contact Person: | Kenneth W Narducy |
| Address: | 650 Poydras St # 2830, New Orleans, Louisiana 70130 |
| Phone Number: | (504) 524-9600 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
St Charles Pharmaceuticals Inc was started in 2000 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Kenneth W Narducy for inquiries that concern St Charles Pharmaceuticals Inc by calling the company number (504) 524-9600, as your correspondence is most welcome. Additionally, the physical location of the single location of St Charles Pharmaceuticals Inc can be found at the coordinates 29.949228,-90.070111 as well as the street address 650 Poydras St # 2830 in New Orleans, Louisiana 70130.
For its online presence, you may visit St Charles Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.